Results 1 to 10 of about 3,292 (173)

Acute Intermittent Porphyria Triggered by COVID-19 Mimicking Guillain-Barré Syndrome: A Diagnostic Challenge. [PDF]

open access: yesClin Case Rep
ABSTRACT Acute intermittent porphyria (AIP) is a rare heme biosynthesis disorder in which the accumulation of neurotoxic porphyrin precursors precipitates neurovisceral attacks. Intercurrent infections, including coronavirus disease 2019 (COVID‐19), may trigger or exacerbate AIP and complicate diagnosis, as clinical manifestations can resemble those of
Sadeghi P   +5 more
europepmc   +2 more sources

Porphyria‐Safe Emergency Management in COVID‐Associated GBS‐Like Neuropathy: Why Early Medication Review Should Accompany PBG/ALA Testing

open access: yesClinical Case Reports
In COVID‐associated acute neuropathy with abdominal pain, seizures, hyponatremia, hypertension, or hepatic involvement, suspected acute intermittent porphyria should prompt both early PBG/ALA testing and immediate porphyria‐safe medication review to ...
Muhammad Abdullah Awan
doaj   +2 more sources

Feigning Acute Intermittent Porphyria [PDF]

open access: yesCase Reports in Psychiatry, 2014
Acute intermittent porphyria (AIP) is an autosomal dominant genetic defect in heme synthesis. Patients with this illness can have episodic life-threatening attacks characterized by abdominal pain, neurological deficits, and psychiatric symptoms. Feigning
Rania Elkhatib   +5 more
doaj   +3 more sources

Successful Pregnancy After Combined Liver and Renal Transplantation in a Patient With Acute Intermittent Porphyria [PDF]

open access: yesCase Reports in Transplantation
Acute intermittent porphyria is a rare inborn disease of porphyrin metabolism which can cause severe abdominal pain attacks and neurological symptoms. Here, we report a patient with a 20-year history of severe chronic manifestations of acute intermittent
Petro E. Petrides   +5 more
doaj   +2 more sources

Acute intermittent porphyria in the puerperium [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2010
Introduction. Acute intermittent porphyria emerges as a result of partial defect of porphobilinogen deaminase and is manifested by repeated episodes of somatic, psychiatric and neurological disorders.
Sparić Radmila   +7 more
doaj   +3 more sources

ACUTE INTERMITTENT PORPHYRIA

open access: yesPakistan Armed Forces Medical Journal, 2011
Acute intermittent porphyria(AIP) is an autosomal dominant, severe form of metabolic disorder affecting females more than males, due to partial deficiency of the enzyme Porphobilinogen Deaminase(PBGD)1.
Abid Ullah Khan   +2 more
doaj   +5 more sources

Acute intermittent porphyria: a test of clinical acumen

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2017
Acute intermittent porphyria (AIP) is a rare autosomal dominant hepatic porphyria due to deficiency of hydroxymethylbilane synthase (HMBS), also known as porphobilinogen deaminase leading to accumulation of porphyrin precursors.
Rashmi Dhital   +3 more
doaj   +2 more sources

Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome [PDF]

open access: yesBMC Neurology
Background Acute intermittent porphyria (AIP) is a rare but treatable disease. COVID-19 has various possible complications including posterior reversible encephalopathy syndrome (PRES).
Hideo Handa   +7 more
doaj   +2 more sources

Reversible Cerebral Vasospasm in Acute Intermittent Porphyria: A Case Report and Review of the Literature

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
The porphyrias are rare inherited diseases of heme biosynthesis which can involve the nervous system. The most common neurological manifestations of acute intermittent porphyria are autonomic visceral neuropathy, peripheral motor neuropathy, and central ...
Attout Hassene, Stephane Guez
doaj   +1 more source

Home - About - Disclaimer - Privacy